4.4 Article

Giant-Cell Myocarditis, Cardiac Sarcoidosis, and Orthotopic Heart Transplantation

Journal

AMERICAN JOURNAL OF CARDIOLOGY
Volume 190, Issue -, Pages 131-135

Publisher

EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjcard.2022.11.032

Keywords

-

Ask authors/readers for more resources

This article describes two clinically diagnosed giant cell myocarditis patients who had short clinical courses before undergoing life-saving heart transplantation. The examination of their hearts revealed multiple widespread yellow lesions in the ventricular walls. The short clinical courses and color differences of myocardial lesions distinguish giant cell myocarditis from cardiac sarcoidosis.
Described herein are 2 patients diagnosed clinically as giant cell myocarditis. Both had short clinical courses (>> 2 months) before lifesaving orthotopic heart transplantation (OHT). Examination of the hearts disclosed multiple widespread yellow lesions in the ven-tricular walls. The short clinical courses in these 2 patients are quite different from car-diac sarcoidosis, which typically has courses lasting years. In contrast to cardiac sarcoidosis, the ventricular myocardial lesions were yellow in color not white as in cardiac sarcoidosis. In conclusion, we consider giant-cell myocarditis and cardiac sarcoidosis to be different conditions and not simply different stages of the same condition. (c) 2022 Pub-lished by Elsevier Inc. (Am J Cardiol 2023;190:131-135)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available